Yuzhi Li

Dr. Yuzhi Li


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
XSXiaominting Song
Xiaominting Song
LTLu Tan
Lu Tan
MWMiao Wang
Miao Wang
CRChaoxiang Ren
Chaoxiang Ren
CGChuanjie Guo
Chuanjie Guo
JPJin Pei
Jin Pei
Myricetin(MYR) is a flavonoid compound widely found in many natural plants including bayberry. So far, MYR has been proven to have multiple biological functions and it is a natural compound with promising research and development prospects. This review comprehensively retrieved and collected the latest pharmacological abstracts on MYR, and discussed the potential molecular mechanisms of its effects. The results of our review indicated that MYR has a therapeutic effect on many diseases, including tumors of different types, inflammatory diseases, atherosclerosis, thrombosis, cerebral ischemia, diabetes, Alzheimer's disease and pathogenic microbial infections. Furthermore, it regulates the expression of Hippo, MAPK, GSK-3β, PI3K/AKT/mTOR, STAT3, TLR, IκB/NF-κB, Nrf2/HO-1, ACE, eNOS / NO, AChE and BrdU/NeuN. MYR also enhances the immunomodulatory functions, suppresses cytokine storms, improves cardiac dysfunction, possesses an antiviral potential, can be used as an adjuvant treatment against cancer, cardiovascular injury and nervous system diseases, and it may be a potential drug against COVID-19 and other viral infections. Generally, this article provides a theoretical basis for the clinical application of MYR and a reference for its further use.

4 September 2020 in Frontiers in Pharmacology
Verified
Journal Article
Open access
YRYali Ren
Yali Ren
XSXiaominting Song
Xiaominting Song
LTLu Tan
Lu Tan
CGChuanjie Guo
Chuanjie Guo
MWMiao Wang
Miao Wang
CPCheng Peng
Cheng Peng
Psoralen is the principal bioactive component in the dried fruits of Psoralea corylifolia L. termed “Buguzhi” in traditional Chinese medicine(TCM). Recent studies have demonstrated that psoralen displays multiple bioactive properties, beneficial for the treatment of osteoporosis, tumors, viruses, bacteria, and inflammation. The present review focuses on the research evidence relating to the properties of psoralen gathered over recent years. Firstly, multiple studies have demonstrated that psoralen exerts strong anti-osteoporotic effects via regulation of osteoblast/osteoclast/chondrocyte differentiation or activation due to the participation in multiple molecular mechanisms of wnt/β-catenin, bone morphogenetic protein (BMP), inositol-requiring enzyme 1 (IRE1) / apoptosis signaling kinase 1 (ASK1)/ c-jun N-terminal kinase (JNK) and the Protein Kinase B(AKT) / activator protein-1 (AP-1) axis, and the expression of miR-488, peroxisome proliferators-activated receptor-gamma (PPARγ), and matrix metalloproteinases (MMPs). In addition, the antitumor properties of psoralen are associated with the induction of ER stress-related cell death via enhancement of PERK: Pancreatic Endoplasmic Reticulum Kinase (PERK)/activating transcription factor (ATF), glucose-regulated protein of 78 (GRP78) / C/EBP homologous protein (CHOP) and glucose-regulated protein of 94 (GRP94)/CHOP signaling, and inhibition of P-glycoprotein (P-gp) or ATPase that overcomes multidrug resistance. Furthermore, multiple articles have shown that the antibacterial, anti-inflammatory and neuroprotective effects of psoralen are a result of its interaction with viral polymerase (Pol), destroying the formation of biofilm, and regulating the activation of tumor necrosis factor alpha (TNF-α), transforming growth factor beta (TGF-β), interleukin 4/5/6/8/12/13 (IL-4/5/6/8/12/13), GATA-3, acetylcholinesterase (AChE), and the hypothalamic-pituitary-adrenal (HPA) axis. Finally, the toxic effects and mechanisms of action of psoralen have also been reviewed.

Verified
Journal Article
Open access
PDF file
GZGuiying Zhao
Guiying Zhao
YRYali Ren
Yali Ren
JYJie Yan
Jie Yan
TZTingrui Zhang
Tingrui Zhang
PLPeng Lu
Peng Lu
YLYuzhi Li
Yuzhi Li
Salvia miltiorrhiza Bunge (Danshen) has been widely used to treat cancer and cardiovascular diseases in Chinese traditional medicine. Here, we found that Neoprzewaquinone A (NEO), an active component of S. miltiorrhiza, selectively inhibits PIM1. We showed that NEO potently inhibits PIM1 kinase at nanomolar concentrations and significantly suppresses the growth, migration, and Epithelial-Mesenchymal Transition (EMT) in the triple-negative breast cancer cell line, MDA-MB-231 in vitro. Molecular docking simulations revealed that NEO enters the PIM1 pocket, thereby triggering multiple interaction effects. Western blot analysis revealed that both NEO and SGI-1776 (a specific PIM1 inhibitor), inhibited ROCK2/STAT3 signaling in MDA-MB-231 cells, indicating that PIM1 kinase modulates cell migration and EMT via ROCK2 signaling. Recent studies indicated that ROCK2 plays a key role in smooth muscle contraction, and that ROCK2 inhibitors effectively control the symptoms of high intraocular pressure (IOP) in glaucoma patients. Here, we showed that NEO and SGI-1776 significantly reduce IOP in normal rabbits and relax pre-restrained thoracic aortic rings in rats. Taken together, our findings indicated that NEO inhibits TNBC cell migration and relaxes smooth muscles mainly by targeting PIM1 and inhibiting ROCK2/STAT3 signaling, and that PIM1 may be an effective target for IOP and other circulatory diseases.

26 April 2024 in Journal of Natural Medicines
Verified
Journal Article
Closed access
PDF file
XZXinyu Zhou
Xinyu Zhou
DZDuanna Zhang
Duanna Zhang
JLJieting Lei
Jieting Lei
JRJixia Ren
Jixia Ren
BYBo Yang
Bo Yang
YLYuzhi Li
Yuzhi Li

13 February 2024 in Phytotherapy Research
Verified
Journal Article
Closed access
YRYa‐Li Ren
Ya‐Li Ren
JLJie‐Ting Lei
Jie‐Ting Lei
TZTing‐Rui Zhang
Ting‐Rui Zhang
PLPeng Lu
Peng Lu
DCDan‐Dan Cui
Dan‐Dan Cui
YLYuzhi Li
Yuzhi Li

Verified
Journal Article
Open access
PDF file
HRHuanan Rao
Huanan Rao
XSXiaominting Song
Xiaominting Song
JLJieting Lei
Jieting Lei
PLPeng Lu
Peng Lu
GZGuiying Zhao
Guiying Zhao
ZCZhi-Xing Cao
Zhi-Xing Cao
Ibrutinib has potential therapeutic or protective effects against viral- and bacterial-induced acute lung injury (ALI), likely by modulating the Bruton tyrosine kinase (BTK) signaling pathway. However, ibrutinib has multi-target effects. Moreover, immunity and inflammation targets in ALI treatment are poorly defined. We investigated whether the BTK-, FLT3-, and EGFR-related signaling pathways mediated the protective effects of ibrutinib on ALI. The intratracheal administration of poly I:C or LPS after ibrutinib administration in mice was performed by gavage. The pathological conditions of the lungs were assessed by micro-CT and HE staining. The levels of neutrophils, lymphocytes, and related inflammatory factors in the lungs were evaluated by ELISA, flow cytometry, immunohistochemistry, and immunofluorescence. Finally, the expression of proteins associated with the BTK-, FLT3-, and EGFR-related signaling pathways were evaluated by Western blotting. Ibrutinib (10 mg/kg) protected against poly I:C-induced (5 mg/kg) and LPS-induced (5 mg/kg) lung inflammation. The wet/dry weight ratio (W/D) and total proteins in the bronchoalveolar lavage fluid (BALF) were markedly reduced after ibrutinib (10 mg/kg) treatment, relative to the poly I:C- and LPS-treated groups. The levels of ALI indicators (NFκB, IL-1β, IL-6, TNF-α, IFN-γ, neutrophils, and lymphocytes) were significantly reduced after treatment. Accordingly, ibrutinib inhibited the poly I:C- and LPS-induced BTK-, FLT3-, and EGFR-related pathway activations. Ibrutinib inhibited poly I:C- and LPS-induced acute lung injury, and this may be due to its ability to suppress the BTK-, FLT3-, and EGFR-related signaling pathways. Therefore, ibrutinib is a potential protective agent for regulating immunity and inflammation in poly I:C- and LPS-induced ALI.